Clinical Trial Update: Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes using Selinexor in combination with induction chemotherapy for children with NUP98 fusion-positive acute myeloid leuke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Nup98 Fusion-positive Acute Myeloid Leukemia

Drugs mentioned

• Selinexor (selinexor)

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: Acute Myeloid Leukemia, Pediatric Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING